PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jmedcasrepBioMed Centralsearchsubmit a manuscriptregisterthis articleJournal of Medical Case ReportsJournal of Medical Case Reports
 
J Med Case Reports. 2009; 3: 130.
Published online 2009 November 17. doi:  10.1186/1752-1947-3-130
PMCID: PMC2803802

Community-acquired mastitis due to Mycobacterium abscessus: a case report

Abstract

Introduction

Mycobacterium abscessus is a rapidly growing mycobacterium usually causing skin and soft tissue infections in immunocompetent patients following contaminated traumatic or surgical wounds or contaminated injected medications. Disseminated infections and pulmonary infections are usually reported in immunocompromised hosts.

Case presentation

We describe a 54-year-old Caucasian woman with mastitis due to M. abscessus. A few days after clinical evidence of mastitis, the patient was started on broad-spectrum antibiotics. Subsequently, due to persistence of symptoms, a percutaneous breast biopsy was performed followed by surgical drainage. Initial cultures failed to grow micro-organisms and tissue histology showed chronic inflammatory reaction with giant cells. Several days after surgery, her symptoms recurred. Finally, M. abscessus breast infection was diagnosed and the patient was treated successfully.

Conclusion

Rapidly growing mycobacteria need to be included in the differential diagnosis of patients with chronic mastitis having pus discharge and who do not respond to broad-spectrum antibiotics.

Introduction

Mycobacterium abscessus is a rapidly growing mycobacterium [1,2] most commonly causing skin and soft tissue infections in immunocompetent patients following penetrating traumatic injuries and concomitant inoculation of M. abscessus into the host tissue [1,3]. Other settings of M. abscessus infections include post-surgical wound infection [3], eye surgery [4] and post-injection abscess [5]. Podiatric care [6] and body piercing [7] have also been associated with such infections. Clustered outbreaks or pseudo-outbreaks have resulted from contaminated ice, water, injected medications [8] or intra-mammary silicone. Disseminated infections and pulmonary infections are reported more often in immunocompromised patients and patients with cystic fibrosis [1,3,9].

We report the case of a patient with mastitis due to M. abscessus who had not undergone surgery nor suffered local trauma.

Case presentation

A 54-year-old Italian, Caucasian woman with a history of autoimmune thyroiditis was seen at the surgical unit for pain, redness and swelling of the left breast which had developed over the preceding 72 hours. The patient had been on 10 mg prednisone for 1 month secondary to autoimmune hemolytic anemia. On physical examination, she was afebrile. Erythema and edema of both areolar and peri-areolar areas of the left breast were present with dimensions of about 9 ×6 cm and with homolateral tender lymph node enlargement. Acute bacterial mastitis was the initial diagnosis and cefotaxime 2 g/day was prescribed for the first 2 weeks. At this point, due to persistence of symptoms, breast ultrasound, mammography, fine needle aspiration, and tru-cut needle biopsies were performed. Histopathology results were consistent with a chronic inflammatory reaction. Subsequently, a draining sinus developed and a pus sample was sterile.

One week later, another swab grew both Pseudomonas luteola and Staphylococcus epidermidis prompting us to perform a second needle aspirate. Cefotaxime 1 g TID and oral ciprofloxacin 500 mg BID were prescribed for a total of 3 weeks. During this period, mild improvement was seen but as the fistula closed her symptoms relapsed so it was decided to perform surgical excision of the abscess. At surgery, galactophora ducts were found to be filled with purulent material. Also a mass of 9.5 × 7 × 5 cm, with cavitation and purulent material, was excised. Once again, histopathology reports showed a chronic inflammatory reaction with giant cells. About 1 week after surgery, the inflammation reappeared and a third needle aspirate was performed. This time, M. abscessus was identified and confirmed in two subsequent cultures [1,2]. Acid-fast bacilli (AFB) were also seen in the pus after Zhiel-Neelsen staining (Figure (Figure1A).1A). At this point, the patient was transferred to the infectious diseases service.

Figure 1
(A) Acid fast bacilli in pus (arrow) on Zhiel-Neelsen staining; (B) Chest CT scan showing a soft tissue abscess 4.5 × 3 cm (arrow) with a cutaneous fistula.

On admission, the patient had an area of inflammation of about 6 × 7 × 4 cm in the external quadrants of her left breast. A few days later, a fistula formed and microbiological tests confirmed the presence of M. abscessus.

The isolated strains were identified by the reverse hybridization method (INNO-LiPA, Belgium) and confirmed by genetic sequencing [1,2]. Antimycobacterial susceptibility tests were performed in microdilution broth (MHB, BioMérieux, France) [10]. M. abscessus results were as follows: susceptible: clarithromycin (MIC 0.125 mg/L) and amikacin (MIC 2 mg/L); intermediate susceptible: cefoxitin (MIC 16 mg/L) and imipenem (MIC 8 mg/L); resistant: ciprofloxacin (MIC 8 mg/L), doxycycline (MIC 8 mg/L), co-trimoxazole (MIC >64 mg/L) and linezolid (MIC 32 mg/L). Abnormal laboratory test results are listed in Table Table1.1. HIV serology was negative, CD4+ lymphocytes were normal and blood cultures were negative for AFB. Therapy consisting of clarithromycin 500 mg BID, imipenem 1 g BID and amikacin 1 g/day was started. The latter was discontinued after 2 weeks due to possible vestibular side effects. Prednisone was also discontinued without recurrence of hemolysis. A chest CT scan confirmed left breast soft tissue and glandular involvement (Figure (Figure1B).1B). Thirty-two days after admission, the inflammation was considerably reduced and the patient was discharged on clarithromycin 500 mg twice a day. Only 1 week later, the patient had to be readmitted because of recurrence. An ultrasound scan showed a hyperechogenic area with hypoechogenicity and aspiration was performed. This time, AFBs were not identified in the pus and the cultures were negative. Imipenem was restarted with clarithromycin for a further 3 weeks. Thereafter, clarithromycin alone was prescribed for another 10 weeks. Eighteen months after treatment discontinuation, the patient remains disease-free.

Table 1
Clinical, laboratory findings and therapy

Discussion

Most M. abscessus infections in immunocompetent patients are caused by either post-traumatic or post-surgical skin and soft tissue inoculation of bacteria [1,3] and some have nosocomial origins [3]. Our patient had no soil or gardening exposure, and did not report any other exposures predisposing to M. abscessus infection. Moreover, it is most likely that the infection was community-acquired and its source cannot be established. The low dose of steroids administered one month before M. abscessus mastitis may have produced some negative immunomodulatory effects predisposing her to infection.

Etiological diagnosis did not occur immediately. Routine bacterial cultures would not be expected to grow mycobacterium, even rapidly growing species.

M. abscessus is resistant to several antibiotics [3,10]. Also, this isolate was only susceptible to clarithromycin and amikacin, while cefoxitin and imipenem had intermediate activity. Our patient received cefotaxime, which had not been tested in vitro, and ciprofloxacin which was resistant. In the end, only the combination of clarithromycin, imipenem and amikacin was truly effective. Side effects included vestibular toxicity and were very likely due to amikacin. This antimicrobial was, therefore, discontinued after 2 weeks and vestibular symptoms regressed. Imipenem and clarithromycin were continued for a total of 4 and a half months [3]. Stains and cultures were negative after the tenth week of treatment.

Conclusion

M. abscessus is a rare cause of skin and soft tissue infection and should be considered in the differential diagnosis of patients who do not respond to standard antibacterial therapy.

Abbreviations

AFB: acid-fast bacilli.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying image. A copy of the written consent is available for review by the Editor-in Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MBP was involved in the diagnosis and treatment of the patient and revised the manuscript critically for content. GA was the main surgeon and was involved in revising the draft. LML was involved in drafting the manuscript. AM and RM carried out the microbiological diagnosis and were involved in revising the manuscript. FB revised the final draft of the manuscript.

Acknowledgements

We would like to thank Dr Enrico Tortoli from the Laboratorio Microbiologia, Ospedale Careggi, Firenze, Italy for reconfirming the isolate typing and susceptibility and for reviewing the manuscript.

References

  • Pfyffer GB, Brown-Elliot BA, Wallance RJ. , Jr. In: Manual of Clinical Microbiology. 8. Murray P, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editor. Vol. 1. Washington, DC: American Society for Microbiology; 2003. Mycobacterium: general characteristics, isolation, and staining procedures; pp. 532–559.
  • Vincent V, Brown-Elliott, Jost KC, Jr, Wallance RJ. , Jr. In: Manual of Clinical Microbiology. 8. Murray P, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editor. Vol. 1. Washington, DC: American Society for Microbiology; 2003. Mycobacterium: phenotypic and genotyping identification; pp. 560–584.
  • Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS. 2006;114:319–328. doi: 10.1111/j.1600-0463.2006.apm_390.x. [PubMed] [Cross Ref]
  • Gonzalez-Fernandez F, Kaltreider SA. Orbital lipogranulomatous inflammation harboring Mycobacterium abscessus. Ophthal Plast Reconstr Surg. 2001;17:374–380. doi: 10.1097/00002341-200109000-00013. [PubMed] [Cross Ref]
  • Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006;142:1287–1292. doi: 10.1001/archderm.142.10.1287. [PubMed] [Cross Ref]
  • Sniezek PJ, Graham BS, Busch HB, Lederman ER, Lim ML, Poggemyer K, Kao A, Mizrahi M, Washabaugh G, Yakrus M, Winthrop K. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol. 2003;139:629–634. doi: 10.1001/archderm.139.5.629. [PubMed] [Cross Ref]
  • Trupiano JK, Sebek BA, Goldfarb J, Levy LR, Hall GS, Procop GW. Mastitis due to Mycobacterium abscessus after body piercing. Clin Infect Dis. 2001;33:131–134. doi: 10.1086/320885. [PubMed] [Cross Ref]
  • Miller L, Mangione E, Beebe J, Hoffman RE, Levy P, Huitt G, Miller GL. Center for Disease Control (CDC) Infection with Mycobacterium abscessus associated with intramuscular injection of adrenal cortex extract - Colorado and Wyoming, 1995-1996. MMWR. 1996;45:713–715. [PubMed]
  • Mueller PS, Edson RS. Disseminated Mycobacterium abscessus infection manifesting as fever of unknown origin and intra-abdominal lymphadenitis: case report and literature review. Diagn Microbiol Infect Dis. 2001;39:33–37. doi: 10.1016/S0732-8893(00)00211-X. [PubMed] [Cross Ref]
  • Inderlied CB, Pfyffer GE. In: Manual of Clinical Microbiology. 8. Murray P, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editor. Vol. 1. Washington, DC: American Society for Microbiology; 2003. Susceptibility test methods: mycobacteria; pp. 1149–1177.

Articles from Journal of Medical Case Reports are provided here courtesy of BioMed Central